Variant report
Variant | esv11299 |
---|---|
Chromosome Location | chr8:3814308-3816551 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368961614 | chr8:3814319-3814320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2740851 | chr8:3814320-3814321 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs377607115 | chr8:3814330-3814331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188084855 | chr8:3814336-3814337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369274349 | chr8:3814341-3814342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566721862 | chr8:3814348-3814349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527577208 | chr8:3814349-3814350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs60055513 | chr8:3814353-3814354 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs570408024 | chr8:3814356-3814357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139032656 | chr8:3814358-3814359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192129045 | chr8:3814363-3814364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567825707 | chr8:3814364-3814365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2948656 | chr8:3814375-3814376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2954646 | chr8:3814378-3814379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs553935232 | chr8:3814379-3814380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371562931 | chr8:3814382-3814383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572339186 | chr8:3814386-3814387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35445335 | chr8:3814394-3814395 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs35752398 | chr8:3814398-3814399 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs539193589 | chr8:3816203-3816204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184809588 | chr8:3816211-3816212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1996898 | chr8:3816221-3816222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs527715589 | chr8:3816238-3816239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150561276 | chr8:3816243-3816244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1996899 | chr8:3816265-3816266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs188156265 | chr8:3816274-3816275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs78161441 | chr8:3816275-3816276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192679015 | chr8:3816281-3816282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535438494 | chr8:3816293-3816294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78389145 | chr8:3816306-3816307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2627496 | chr8:3816309-3816310 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs374700423 | chr8:3816315-3816316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114614357 | chr8:3816341-3816342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140119782 | chr8:3816343-3816344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566434568 | chr8:3816367-3816368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs17068216 | chr8:3816368-3816369 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs558016992 | chr8:3816376-3816377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558583097 | chr8:3816390-3816391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570459151 | chr8:3816399-3816400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73178017 | chr8:3816400-3816401 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs556330241 | chr8:3816403-3816404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143839286 | chr8:3816419-3816420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540337594 | chr8:3816456-3816457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145849099 | chr8:3816465-3816466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535159392 | chr8:3816477-3816478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554067525 | chr8:3816478-3816479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148592028 | chr8:3816483-3816484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545878361 | chr8:3816498-3816499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564550101 | chr8:3816500-3816501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529232230 | chr8:3816514-3816515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3813800-3814400 | Enhancers | HepG2 | liver |
2 | chr8:3816200-3816400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr8:3816200-3816400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr8:3816200-3817600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr8:3816400-3817000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr8:3816400-3817200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |